Adaptive Biotechnologies Corp (ADPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 93,973 | 58,879 | 52,443 | 47,459 | 46,435 |
| Cost of Goods | 18,157 | 17,999 | 16,979 | 18,045 | 16,667 |
| Gross Profit | 75,816 | 40,880 | 35,464 | 29,414 | 29,768 |
| Operating Expenses | 65,683 | 66,915 | 66,047 | 63,296 | 63,067 |
| Operating Income | 10,290 | -25,036 | -29,604 | -33,837 | -32,632 |
| Interest Expense | 2,971 | 2,948 | 2,905 | 2,952 | 2,939 |
| Other Income | 2,226 | 2,391 | 2,679 | 3,072 | 3,474 |
| Pre-tax Income | 9,545 | -25,593 | -29,830 | -33,717 | -32,097 |
| Net Income Continuous | 9,545 | -25,593 | -29,830 | -33,717 | -32,097 |
| Minority Interests | -1 | 21 | 22 | -25 | -26 |
| Net Income | $9,546 | $-25,614 | $-29,852 | $-33,692 | $-32,071 |
| EPS Basic Total Ops | 0.06 | -0.17 | -0.20 | -0.22 | -0.22 |
| EPS Basic Continuous Ops | 0.06 | -0.17 | -0.20 | -0.23 | -0.22 |
| EPS Diluted Total Ops | 0.06 | -0.17 | -0.20 | -0.22 | -0.22 |
| EPS Diluted Continuous Ops | 0.06 | -0.17 | -0.20 | -0.23 | -0.22 |
| EPS Diluted Before Non-Recurring Items | -0.15 | -0.17 | -0.20 | -0.23 | -0.22 |
| EBITDA(a) | $14,179 | $-21,284 | $-25,831 | $-30,847 | $-30,049 |